How wearable seizure monitoring for children and adults with epilepsy can improve delivery of care

Dec 01, 2023 - 5 min. read

We showcase the potential clinical utility of mid-to-long term monitoring in epilepsy care using a non-invasive, discreet wearable for use in daily life. The preliminary 84 % positive clinical impact indicates EpiCare@Home can deliver actionable medical insights based on real-world data that supports more informed and timely decisions to improve the delivery of care for those affected by epilepsy.

Julie Nys
Clinical Lead

How wearable seizure monitoring for children and adults with epilepsy can improve delivery of care

Dec 01, 2023 - 5 min. read

We showcase the potential clinical utility of mid-to-long term monitoring in epilepsy care using a non-invasive, discreet wearable for use in daily life. The preliminary 84 % positive clinical impact indicates EpiCare@Home can deliver actionable medical insights based on real-world data that supports more informed and timely decisions to improve the delivery of care for those affected by epilepsy.

Reach out to our experts

How wearable seizure monitoring for children and adults with epilepsy can improve delivery of care

Dec 01, 2023 - 5 min. read

We showcase the potential clinical utility of mid-to-long term monitoring in epilepsy care using a non-invasive, discreet wearable for use in daily life. The preliminary 84 % positive clinical impact indicates EpiCare@Home can deliver actionable medical insights based on real-world data that supports more informed and timely decisions to improve the delivery of care for those affected by epilepsy.

Reach out to our experts

Addressing uncertainty in epilepsy

For people with epilepsy, the journey to a working treatment and an acceptable quality of life may be long and cumbersome. The lack off real-world seizure information is one major bottleneck. There is a need for accurate and user-friendly multimodal seizure monitoring devices to assess seizure frequency and burden outside the hospital over longer periods of time via remote patient monitoring (RPM).

An end-to-end remote patient monitoring service

EpiCare@Home combines a discreet wearable for continuous, objective monitoring of epileptic activity using multimodal signals (EEG, ECG, motion) with logistics, a patient App and a healthcare professional dashboard.  

Virtual care and real-world data deliver impact

A retrospective case review was done to assess the clinical and patient value reached after remote monitoring in people with a suspicion or diagnosis of epilepsy

Conclusion and outlook

We showcase the potential clinical utility of mid-to-long term monitoring in epilepsy care using a non-invasive, discreet wearable for use in daily life. The preliminary 84 % positive clinical impact indicates EpiCare@Home can deliver actionable medical insights based on real-world data that supports more informed and timely decisions to improve the delivery of care for those affected by epilepsy.

Subscribe to our newsletter and follow our journey:

Request sample patient reports:

Full reports available for all flows.

See what you can expect from our data & insight collection.

Patient demo report

Addressing uncertainty in epilepsy

For people with epilepsy, the journey to a working treatment and an acceptable quality of life may be long and cumbersome. The lack off real-world seizure information is one major bottleneck. There is a need for accurate and user-friendly multimodal seizure monitoring devices to assess seizure frequency and burden outside the hospital over longer periods of time via remote patient monitoring (RPM).

An end-to-end remote patient monitoring service

EpiCare@Home combines a discreet wearable for continuous, objective monitoring of epileptic activity using multimodal signals (EEG, ECG, motion) with logistics, a patient App and a healthcare professional dashboard.  

Virtual care and real-world data deliver impact

A retrospective case review was done to assess the clinical and patient value reached after remote monitoring in people with a suspicion or diagnosis of epilepsy

Conclusion and outlook

We showcase the potential clinical utility of mid-to-long term monitoring in epilepsy care using a non-invasive, discreet wearable for use in daily life. The preliminary 84 % positive clinical impact indicates EpiCare@Home can deliver actionable medical insights based on real-world data that supports more informed and timely decisions to improve the delivery of care for those affected by epilepsy.

Additional Audio resources:

Subscribe to our newsletter and follow our journey:

Related articles